Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582066 | SCV000691668 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530809 | SCV002951221 | likely benign | Li-Fraumeni syndrome | 2024-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582066 | SCV004849327 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-09-06 | criteria provided, single submitter | clinical testing | The c.96+12G>C intronic alteration consists of a G to C substitution 2 nucleotides after coding exon 2 in the TP53 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |